A detailed history of Jfs Wealth Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Jfs Wealth Advisors, LLC holds 10 shares of EMBC stock, worth $148. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10
Previous 10 -0.0%
Holding current value
$148
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 07, 2024

SELL
$12.87 - $19.09 $270 - $400
-21 Reduced 67.74%
10 $0
Q3 2023

Nov 02, 2023

SELL
$15.0 - $22.17 $150 - $221
-10 Reduced 24.39%
31 $0
Q2 2023

Aug 07, 2023

SELL
$21.6 - $30.69 $64 - $92
-3 Reduced 6.82%
41 $0
Q1 2023

Apr 19, 2023

SELL
$23.07 - $32.77 $92 - $131
-4 Reduced 8.33%
44 $1,000
Q4 2022

Feb 13, 2023

BUY
$25.29 - $35.48 $202 - $283
8 Added 20.0%
48 $1,000
Q3 2022

Oct 21, 2022

BUY
$24.0 - $33.42 $48 - $66
2 Added 5.26%
40 $1,000
Q2 2022

Aug 02, 2022

BUY
$24.78 - $33.36 $941 - $1,267
38 New
38 $1,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $859M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Jfs Wealth Advisors, LLC Portfolio

Follow Jfs Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jfs Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jfs Wealth Advisors, LLC with notifications on news.